Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $20.1 million.

  • CureVac N.V's Depreciation & Amortization (CF) fell 9.61% to $5.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.4 million, marking a year-over-year decrease of 18.26%. This contributed to the annual value of $20.1 million for FY2024, which is 20.12% down from last year.
  • Latest data reveals that CureVac N.V reported Depreciation & Amortization (CF) of $20.1 million as of FY2024, which was down 20.12% from $25.2 million recorded in FY2023.
  • CureVac N.V's 5-year Depreciation & Amortization (CF) high stood at $25.2 million for FY2023, and its period low was $12.7 million during FY2020.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $24.2 million (2022), whereas its average is $23.2 million.
  • As far as peak fluctuations go, CureVac N.V's Depreciation & Amortization (CF) skyrocketed by 60.45% in 2020, and later decreased by 20.12% in 2024.
  • Yearly analysis of 5 years shows CureVac N.V's Depreciation & Amortization (CF) stood at $12.7 million in 2020, then skyrocketed by 40.93% to $17.9 million in 2021, then surged by 35.09% to $24.2 million in 2022, then grew by 3.88% to $25.2 million in 2023, then dropped by 20.12% to $20.1 million in 2024.